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Abstract
Background:A variety of studies have considered the affects of India’s son preference on gender
differences in child mortality, sex ratio at birth, and access to health services. Less research has
focused on the affects of son preference on gender inequities in immunization coverage and how
this may have varied with time, and across regions and with sibling compositions.We present a
systematic examination of trends in immunization coverage in India, with a focus on inequities in
coverage by gender, birth order, year of birth, and state.
Methods: We analyzed data from three consecutive rounds of the Indian National Family Health
Survey undertaken between 1992 and 2006.All children below five years of age with complete
immunization histories were included in the analysis.Age-appropriate immunization coverage was
determined for the following antigens:bacille Calmette-Guérin (BCG),oral polio (OPV),diphtheria,
pertussis (whooping cough) and tetanus (DPT), and measles.
Results: Immunization coverage in India has increased since the early 1990s, but complete, age-
appropriate coverage is still under 50% nationally. Girls were found to have significantly lower
immunization coverage (p<0.001) than boys for BCG,DPT,and measles across all three surveys.By
contrast,improved coverage of OPV suggests a narrowing of the gender differences in recent years.
Girls with a surviving older sister were less likely to be immunized compared to boys, and a large
proportion of all children were found to be immunized considerably later than recommended.
Conclusions: Gender inequities in immunization coverage are prevalent in India. The low
immunization coverage, the late immunization trends and the gender differences in coverage
identified in our study suggest that risks of child mortality,especially for girls at higher birth orders,
need to be addressed both socially and programmatically.
Abstract in Hindi: See the full article online for a translation of this abstract in Hindi.
Open AccessAbstract in Hindi
See Additional file 1 for a translation of the abstract to
this article in Hindi.
Background 
In India there is a well-documented history of son prefer-
ence [1-4]. A growing body of literature has examined the
impacts of India’s son preference on child survival, juvenile
sex ratio, and the numbers of ‘missing’ women [5-10]. There
is evidence that the son preference in India and other South
Asian countries contributes to disadvantage in women’s
health throughout the life course [11]. Disadvantage for girls
in India begins with a reduced chance of being born at all,
and those who are born face lower access to preventive care
and treatment of disease compared to boys [6,11,12]. 
Girls born in India have a 40% greater risk of ill health
compared to boys and are less likely to access health care,
in particular immunization [11,13,14]. Boys, however, are
more likely than girls to die in the first month of life from
perinatal conditions, such as birth asphyxia and birth
trauma. Only two other conditions (unintentional
injuries and congenital anomalies) are more common
among boys than girls. Beyond these causes, and contrary
to the trends observed in most of the world, in India more
girls than boys die of acute respiratory diseases, infectious
and parasitic diseases, and viral infections [15,16]. 
Many of the deaths among India’s children are avoidable,
including those from the childhood cluster of vaccine pre-
ventable diseases (especially measles and tetanus), malaria,
diarrhoea caused by organisms such as rotavirus, and acute
respiratory infections caused by Streptococcus pneumonia
and Hæmophilus influenza type b (HiB). Recent data shows
that immunization – long established worldwide as a high-
ly cost-effective lifesaver – still reaches only a minority of
India’s children, even after the substantial improvements in
vaccination coverage against measles and polio. To make
matters worse, girls are especially vulnerable due to
inequities in access to immunization coverage [17]. 
Preference for sons in India has been noted to vary across
regions, levels of fertility, and order of birth [1,18-20]. A
wide variety of studies have examined the affects of
India’s son preference on child mortality and India’s sex
ratio in light of changing fertility patterns and concern for
‘missing’ women. Less research has focused on the influ-
ence of India’s son preference on gender inequities in
access to health care, specifically immunization, and how
this may have varied with time and across regions. In this
article we investigate the presence of gender inequities in
terms of access to timely immunization coverage. We will
focus on trends in gender inequities at the national level,
by birth order, and by state of residence using data col-
lected from 1992 to 2006. 
Previous research
Inequities in immunization coverage by gender have been
shown to exist throughout India [12]. Of the 17 major
states, 10 have demonstrated inequity in full immuniza-
tion coverage against girls. Even states that perform well
in immunization coverage struggle with considerably dif-
ferent immunization rates between boys and girls [20]. A
search of available literature yielded several studies
reporting lower immunization coverage among girls as
compared to boys. A study of more than 4000 rural
Indian children in 1993-1994 indicated that fewer than
55% of children were fully vaccinated and that girls had a
5% lower coverage compared to boys [17]. In 1992, Bonu
et al evaluated vaccination coverage among children aged
12-35 months before and after a three-year government
vaccination-awareness program in rural areas of four
north Indian states. Prior to the program, girls were found
to be at a disadvantage compared to boys and the differ-
ences in coverage by gender persisted following the
program’s completion [21]. Other studies reviewed indi-
cated lower immunization coverage for girls compared to
boys, although differences were non-significant [22,23].
We compiled data from these four studies comprising
nine sub-samples (based on a combination of different
age groups and antigens) to obtain an overall ratio of cov-
erage (girls vs. boys). We observed an overall coverage
ratio estimate of 0.93 (95% CI: 0.90, 0.9, Figure 1) – indi-
cating that among these studies girls were 7% less likely to
be immunized when compared to boys (p<0.001). 
Methods
Data sources
This study uses data from three consecutive rounds of the
Indian National Family Health Survey (NFHS) [24-26].
The International Institute for Population Sciences coor-
dinated each round of the survey with support from
several international organizations. The three cross-sec-
tional surveys were conducted during 1992-93, 1998-99
and 2005-06. A summary of the coverage and target pop-
ulation for each round is presented in Table 1. The
sampling, questionnaire structure, and content of the
NFHS surveys follow what has been adopted by the
Demographic Health Surveys (DHS) in other developing
countries. The NFHS uses nationally representative area-
based sampling frames in each survey [27]. The NFHS
produced high response rates in all states.  Details of the
survey methodology and response rates have been pub-
lished for each round of the survey [24-26]. 
Sample for analysis
Our sample for analysis includes all children below five
years of age with complete immunization histories (N =
121,100). The 1998-1999 survey only included children
up to 35 months of age at the time of the survey. About
BMC International Health and Human Rights 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1472-698X/9/S1/S3
Page 2 of 12
(page number not for citation purposes)3% of children were excluded due to missing data on
immunization coverage. Total sample sizes of children
under five along with analysis samples for each round of
the NFHS are detailed in Table 1. 
Indicators and measures
We defined immunization coverage as up to date, age-
appropriate immunization coverage. Standard indicators
of immunization coverage are based on the percentage of
children who have accumulated the required number of
vaccines by a certain age, regardless of timeliness. Age-
appropriate vaccination has been shown to be an
important component of infection control [28,29] by
reducing transmissibility in susceptible populations
[30,31] and by increasing the probability of survival [32].
We determined age-appropriate immunization coverage
for each antigen using a combination of data from the
child’s immunization card and maternal recall when
cards were unavailable. Previous studies have demonstrat-
ed that maternal recall can be a robust estimation of
immunization coverage in settings where complete
records are not available [33]. 
Immunization information was available for the follow-
ing antigens: bacille Calmette-Guérin (BCG), oral polio
vaccine (OPV), diphtheria, pertussis (whooping cough)
and tetanus (DPT) vaccine, and measles vaccine. We con-
sidered children age-appropriately immunized if they had
received all immunizations for their age according to the
WHO’s Expanded Program on Immunization (EPI)
immunization schedule. Modelled on the WHO guide-
lines, the government of India’s Universal Immunization
Program (UIP) was introduced in 1985 and includes one
dose of BCG (at birth), three doses of OPV and DPT (at 6,
10, and 14 weeks), and one dose of measles (at nine
months) [34]. India’s EPI/UIP schedule used for our age-
appropriate classification is detailed in Figure 2.
Using the child’s age in months and the EPI schedule, a
composite binary variable indicating EPI complete (yes or
no) was created to represent the overall age-appropriate
immunization status of each child as follows: 
0-1 month: child was considered age-appropriately
immunized (EPI=1) if they had received BCG; 
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Table 1 - Overview of India’s National Family Health Survey (NFHS).
Survey Phase
1992-1993 1998-1999  2005-2006 
(NFHS-1) (NFHS-2) (NFHS-3)
Sample size (women) 89,777 91,000 230,000
Age group (women) 13-49 15-49 15-49
Data collection period
Start April 1992 Nov 1998 Dec 2005
Finish Sept 1993 Dec 1999 Aug 2006
Number of states 25 26 29
Living cohorts 1988-1993 1996-1999 2001-2006
Total sample (living  45,275 30,821 48,468
children under 5)
Sample included in analysis 43,732 29,669 47,709
Reference period for 
immunization coverage
Start Jan 1988 Jan 1996 Jan 2001
Finish Aug 1993 Dec 1999 Aug 2006
Figure 1 - Girl-to-boy ratios of immunization coverage and combined estimates derived from previously
published studies.
The girl-to-boy immunization coverage ratios are based on the results of studies where data was available for calculation of
pooled estimates. A CR of less than 1.0 indicates higher coverage in favour of boys.2-3 months: child was considered age-appropriately
immunized (EPI=1) if they had received BCG and two
doses of OPV and DPT (one dose of OPV and DPT if aged
two months); 
4-8 months: child was considered age-appropriately
immunized (EPI=1) if they had received BCG and three
doses of OPV and DPT; 
9 months and older: child was considered age-appropri-
ately immunized (EPI=1) if they had received BCG, three
doses of OPV and DPT, and one dose of measles. 
To study the influence of birth order and gender of the
older siblings, we calculated the birth order and gender of
each child in relation to the birth order and gender of
their siblings. In a subset of children for whom the com-
plete date of birth (day, month, and year) was known and
complete date of immunization was recorded on the
immunization card, we calculated age of vaccine receipt
for all EPI antigens.
Data analysis
The analyses in this paper are primarily descriptive and
present gender differences in immunization coverage by
antigen, birth order, year of birth, and state across the
three rounds of the NFHS survey. Using the composite EPI
age-appropriate variable, we examined gender differences
in coverage by birth order and sibling composition. We
also examined the change in age-appropriate coverage by
birth cohort  (based on year of birth) for each EPI antigen.
Births that occurred near to the time of the survey are
excluded from the cohort analyses in order to prevent
underestimates of coverage due to reduced opportunity to
receive complete immunizations among these children.
We instead report proportion of children not immunized
for these birth cohorts. Gender differences in immuniza-
tion coverage are presented at the state and national level.
Sampling weights were used for all analyses. We tested dif-
ferences between proportions using t statistics. Data were
managed and analyzed using Stata (version 10) statistical
software [35].
Results 
Gender inequities in age-appropriate immunization
coverage
Immunization coverage has increased in India since
1992-1993 (Figure 3), but age-appropriate EPI coverage
remains below 50% nationally for both boys and girls.
Coverage of OPV has improved substantially according to
the 2005-2006 data, but progress has not been as marked
for DPT and Measles. 
At the national level, age-appropriate BCG coverage
among boys increased from 58.2% (95%CI 57.4; 59.0) in
1992-1993 to 76.0% (95%CI 75.3; 76.7) in 2005-2006.
BCG coverage for girls increased from 54.9% (95%CI
54.1; 55.7) in 1992-1993 to 73.1% (95%CI 72.3; 73.8) in
2005-2006. Differences in BCG coverage between girls
and boys indicate that girls still have lower access to BCG
at the national level (p<0.001, in all three periods). 
The percent of boys with age-appropriate OPV coverage
increased from 50.1% (95%CI 49.3; 50.8) in 1992-1993
to 78.7% (95%CI 78.1; 79.4) in 2005-2006 and from
47.0% (95%CI 46.2; 47.8) in 1992-1993 to 77.5%
(95%CI 76.8; 78.2) in 2005-2006 for girls. The most dra-
matic increase in age-appropriate OPV coverage has
happened between 1998-99 and 2005-2006, but compar-
ison of the coverage for boys and girls at the national level
still shows significantly lower OPV coverage (p=0.012)
among girls. 
Coverage of DPT has shown less improvement. According
to the 1992-1993 data, age-appropriate DPT coverage
among boys was 48.5% (95%CI 47.7; 49.3), reaching
52.4% (95%CI 51.4; 53.3) in 1998-1999 and climbing
only a few percent points in 2005-2006 to 55.7% (95%CI
54.9; 56.5). Coverage for girls has increased from 45.1%
(95%CI 44.3; 46.0) in 1992-1993 to 49.8% (95%CI 48.8;
50.7) and to 53.3% (95%CI 52.5; 54.2) in 1998-1999 and
2005-2006, respectively. Girls, however, are experiencing
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Figure 2 - Recommended expanded program of
immunization (EPI) schedule for India.
*OPV-0 is an additional dose of polio given at birth, but is
not part of India’s national immunization program. †Dashed
lines indicate ages (1,2,3,5, and 9 months) used in
determining appropriate immunization coverage within the
child’s first year. Children were considered to have age-
appropriate EPI coverage if they had received all antigens
recommended for their age.significantly lower coverage rates compared to boys
(p<0.001, in all three periods). 
Measles, an antigen that requires over 95% coverage to
stop transmission in a population, still has very low cov-
erage rates in India. For boys, there has been an increase
in age-appropriate coverage from 43.9% (95%CI 43.0;
44.8) in 1992-1993 to 58.6% (95%CI 57.8; 59.5) in
2005-2006. Age-appropriate coverage among girls
increased from 40.7% (95%CI 39.9; 41.6) in 1992-1993
to 56.1% (95%CI 55.2; 57.0) in 2005-2006. Differences
in coverage by gender are still significant (p<0.05) with
girls experiencing lower coverage than boys. Large increas-
es can still be made in the overall levels of coverage of
measles vaccination. 
As can be noted from the gender specific coverage rates
reported above, gender differences in vaccination cover-
age are consistent and significant, but do not appear to
have increased over time. Girls’ coverage for every antigen
lags behind boys’ coverage in all years, but neither gender
displays acceptable age-appropriate coverage levels for
any antigen (Figure 3). 
Inequities in age-appropriate immunization coverage due
to birth order
Birth order and family composition is an important pre-
dictor of vaccination coverage. Higher birth order is
associated with a lower probability of being age-
appropriately immunized. Despite the increase in rates of
age-appropriate immunization coverage over time, the
gender gap has not been reduced. Girls are much less
likely to be up to date with their immunization at any
given age. Furthermore, the gap increases with birth order
unless a girl has an older brother. Girls who are born third
to a family with two other girls are in the extreme of
immunization disadvantage, when compared to boys
who are born third to families with two older girls. Only
36.1 % (95%CI 33.3; 39.0) of third born girls with two
older sisters are appropriately immunized for their age
compared to 45.0% (95%CI 42.3; 47.8, Figure 4) of the
third order boys with two older sisters. Higher birth order
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Figure 3 - Percent of children with age-appropriate coverage, by gender, antigen, and date of survey.
Period of NFHS Surveys: 92-93 (NFHS 1), 98-99 (NFHS 2), and 05-06 (NFHS 3).Vertical bars represent 95% confidence
intervals (CI).children (third or higher) with mixed gender sibling (i.e.
brothers and sisters) composition have very low age-
appropriate immunization coverage, not reaching 30%.
Still, girls are experiencing lower coverage rates compared
to boys. 
This trend is inverted for third order births following two
older boys (Figure 4). In this situation, the gender gap is
not as pronounced. Like all children at higher birth
orders, these children are vulnerable to lower age-appro-
priate immunization coverage. Indeed, the coverage rates
for these children are lower in 2005-2006 than rates
observed for first order children born more than 10 years
before (i.e. in 1992-1993, Figure 4).
Trends in gender inequities over time
We present trends in age-appropriate immunization cov-
erage by birth cohort and antigen in Figure 5.
Age-appropriate immunization by gender is presented for
children born during the years between 1988 and 1993,
between 1996 and 1999, and between 2001 and 2006
inclusive. For children born during the survey years
(1992-93 for NFHS-1, 1997-98 for NFHS-2, and 2005-6
for NFHS-3), we present the proportion of children not
age-appropriately immunized in Figure 6. 
Age-appropriate coverage of BCG increased over the
cohorts analysed for both boys and girls. In the majority
of cohorts, girls received lower age-appropriate BCG cov-
erage than boys. This difference remained significant for
children born in 2003 and 2004 (p<0.05), Figure 5. For
children where the date of immunization was recorded,
the median age of receiving BCG decreased from 11.3
weeks in 1990 to 7.0 weeks in 1996 and to 4.7 weeks in
2003. For boys the decrease has been from an age of 11.6
weeks in 1990 to 6.7 weeks in 1996 and to 4.6 weeks in
2003. The WHO/EPI recommendation is that BCG be
administered at birth or first contact with health services.
Our results indicate a considerable delay in BCG coverage
for both boys and girls (see web appendix in Additional
file 2). The proportion of boys and girls born during the
survey years who were not vaccinated are presented in
Figure 6. These estimates are cross-sectional and should
be interpreted taking into account future opportunity for
immunization. 
Age-appropriate coverage of OPV has improved from
1988 to 2004 and similar coverage for both boys and girls
has been achieved in recent birth cohorts. Where infor-
mation is available, it is noted that the age of receiving
OPV-1 has been reduced from a median of approximate-
ly 13 weeks in 1990 (boys and girls) to less than nine
weeks in 2003, near to the recommended age of six weeks.
The median time to the second and third polio dose
remains above the WHO recommendation of 10 and 14
weeks, respectively (Additional file 2). There has been a
reduction in median age for receiving OPV-2 from 18
weeks (for all children) in 1990, to 15 weeks in 2003. The
median age to receive OPV-3 was 24 weeks for boys and
33 weeks for girls in 1990. This has been reduced to 21
weeks for boys and 27 weeks for girls in 2003. Girls born
in 2003 received OPV-3 more than 13 weeks later than
recommended. 
Important gender inequities in DPT coverage were noted
for children born in 1989, 1991, and 1996. These
inequities have not persisted for children born in 2001-4
(Figure 5). Overall levels of DPT coverage have, however,
remained below 60% for boys and girls. The median age
for receiving the first DPT dose was seven weeks later than
recommended for girls and boys in 1990. This has
reduced to three weeks later than recommended for chil-
dren born in 2003 (Additional file 2). Boys and girls born
in recent years are also receiving the second and third DPT
doses earlier (Additional file 2).
There has been an increase in age-appropriate measles
immunization coverage for boys and girls born in 2004
compared with children born in 1988. A difference in
coverage between girls and boys is still apparent, even for
children born in recent years. Girls born in 2004 had sig-
nificantly (p<0.05) lower coverage than boys born in the
same year. Both girls and boys continue to receive the
measles vaccine about six weeks later than recommended
(Additional file 2). 
Age at immunization
Across all antigens, the distributions of age at immuniza-
tion demonstrate significant positive skew (Additional
file 2). The children at upper tails of these distributions
are being immunized extremely late. This indicates that a
sizable amount of children are behind the recommended
immunization schedule for all of the evaluated antigens.
The median age at immunization appears to be decreas-
ing, suggesting an increase of children being vaccinated
on time for those born in recent years. Considerable
variability exists in the sample sizes available in each birth
cohort due to incomplete data on child’s date of birth
and/or dates of immunization. There does not appear to
be large gender inequities in terms of age at immuniza-
tion, but a sizeable number of children are behind the
recommended immunization schedule for all the evaluat-
ed antigens (Additional file 2).
Gender inequities in immunization coverage by state and
region in India
Substantial variation in levels of EPI coverage for boys and
girls exists between states in India (Figure 7).
Immunization coverage was not strongly correlated with
gender inequities in coverage (Pearson’s r = 0.06). Six out
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Figure 4 - Percent of children with age-appropriate coverage of EPI vaccines, by birth order, gender of
previous birth(s), and survey period.
Overall (EPI) age-appropriate immunization coverage for girls and boys at each birth order (column 1) and sibling gender
composition of previous birth(s) (column 2) is represented by the bar chart for each year of the survey period (column 3).
†Percentages in brackets (column 1) are the proportion of all births represented by each category of birth order and sibling
gender in the 2005-6 survey. Horizontal bars represent 95% CI.of the fifteen states that perform above the national aver-
age in immunization coverage are also among the eight
states with the lowest ratios of girl-to-boy immunization
coverage (Figure 7). Nationally, the girl-to-boy ratio of
immunization coverage is 0.95 (p<0.001), demonstrating
that 5% fewer girls than boys are fully immunized. 
The three states with the lowest girl-to-boy ratios of immu-
nization coverage are the northern states of Punjab,
Haryana, and Bihar. In these states, between 10 and 14%
fewer girls than boys are fully immunized. Other northern
states, including Uttar Pradesh and Delhi, demonstrate low
girl-to-boy coverage ratios (0.92, and 0.93, respectively)
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Figure 5 - Trends in age-appropriate immunization coverage of EPI antigens in India by antigen, gender, and
year of birth.
Years of birth covered by NFHS surveys are indicated by solid points and lines. Dashed lines indicate periods where data is
not available.Vertical bars represent 95% CI.although these differences in coverage are not statistically
significant. The southern Indian states of Tamiml Nadu
and Keral demonstrate high levels of immunization cov-
erage (80.5% and 75.4%, respectively) and near equity in
coverage by gender. Gender inequities in immunization
coverage are not clearly determined by a north south
divide. Two northern states, Himachal Pradesh and
Rajasthan, demonstrate an immunization coverage ratio
that favours girls (Figure 7). Additionally, the southern
state of Andhra Pradesh demonstrates a large difference in
coverage favouring boys (0.93, p=n.s.). The northeastern
states of Jharkhand and Assam demonstrate the largest
coverage ratios in favour of girls, but are among the states
with the lowest coverage rates. 
Using proportions of children not appropriately immu-
nized for their age in 2005-6 and population data from
the 2001 Census [36], we estimate that, nationally, up to
31M girls and 32M boys aged 0 to four are lacking age-
appropriate immunization coverage in India. We present
estimated numbers of children lacking age-appropriate
coverage for boys and girls aged 0 to four in 21 states in
Figure 7. Nationally, and for many states, the absolute
number of boys exceeds the number of girls lacking com-
plete age-appropriate immunization coverage. This is due
to gender imbalances in India’s population structure,
leading to fewer girls than boys at these ages [6,36]. 
Discussion 
Using three nationally representative surveys from India,
our findings indicate that, at the national level, girls have
lower immunization coverage than boys. We noted that
girls at higher birth orders and with older sisters are at
greater risk of missing antigens compared to boys of the
same birth order and sibling gender composition.
Analyses of children by birth year revealed consistently
lower coverage of BCG and measles for girls  compared to
boys, while also suggesting that gender inequities in OPV
BMC International Health and Human Rights 2009, 9(Suppl 1):S3 http://www.biomedcentral.com/1472-698X/9/S1/S3
Page 9 of 12
(page number not for citation purposes)
Figure 6 - Percentage of children without age-appropriate immunization coverage in India at the time of each
NFHS survey, by antigen and gender.
We calculated the percentage of children born during each survey period who were not appropriately covered for each
antigen according to their age.Vertical bars represent 95% CI.and DPT coverage may have narrowed for children born
in recent years. Gender inequity in immunization cover-
age was found to be greatest in three northern Indian
states, consistent with previous findings of strong son
preference in these areas [1,7,19]. The gender inequities
in access to preventive care in India noted here are likely
to reflect, at least in part, the societal preference for sons
in India [11,20]. 
Our estimates are lower than those published in the
NFHS reports as these reports do not account for the time-
liness of vaccine delivery [24-26]. Analyses of age at
immunization indicated minimal differences between
girls and boys for all antigens, suggesting a child's gender
may affect the decision to immunize, but not timeliness
of coverage. 
The use of age-appropriate immunization coverage rates
as a health indicator can aid in determining the conse-
quences of not receiving timely vaccination. In our
analysis, a substantial number of boys and girls were
receiving BCG between one and two years after birth.
Studies in the US indicate that the timeliness of immu-
nization coverage can have a considerable impact on
child survival [37,38]. In Bangladesh, a study revealed
timely BCG immunization could reduce the mortality risk
up to 40% for children vaccinated between 60 and 180
days of life and up to 80% for children vaccinated within
the first 60 days of life [32]. Similar results have been
shown for the effect of age-appropriate DPT immuniza-
tion and the risk of pertussis [39]. Socioeconomic
characteristics associated with delayed immunization
have been rarely studied in India [40] and further research
is needed in this area. 
Our finding that gender inequities in immunization cov-
erage are not correlated with overall immunization
coverage is consistent with previous studies [12,20].
Several states with low girl-to-boy coverage ratios (e.g.
Punjab, Haryana, and Delhi) are performing above the
national average in terms of overall coverage. Data from
the DHS in India and other South Asian countries indi-
cate that the gender differences in immunization coverage
are observed among all socio-economic levels, with some
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Figure 7 – Percentage of children with age-appropriate EPI coverage, girl-to-boy coverage ratio, and number
of children without age-appropriate immunization coverage in India (2005-2006), by state and gender.
NFHS 3 data and state-level sampling weights were used for this figure. †Absolue number of children without age-appropriate
EPI coverage, estimated from the 2001 Indian Census [34]. *CR, coverage ratio, girls vs. boys **p ≤0.001.indication that differences may be larger among the rich
than among the poor [12]. 
Gender inequity in access to health services is believed to
be one consequence of larger societal circumstances
across South Asia that favour boys and leads to the mar-
ginalization of women from a young age [11]. An
exploration of socioeconomic and sociocultural determi-
nants of gender inequities in immunization coverage is
beyond the scope of this work. Readers are referred to
other studies investigating the determinants of gender
inequities in sex ratios [6,7], child mortality [5,41,42] fer-
tility patters [1,2], and nutrition [17,20]. Further
investigation into the determinants of continuing gender
inequities in India’s immunization coverage is required. 
Along with improved nutrition, immunization is a major
tool for saving children’s lives, standing out, even in set-
tings of very low income, as a highly cost-effective and
efficient intervention [43]. Currently, in India, two-thirds
of the children who die of measles and other preventable
childhood diseases would have survived if they had had
access to immunization. The additional annual per capita
cost necessary to reach 90% of Indian children with the
six basic vaccines already included in the national immu-
nization program – diphtheria, tetanus, pertussis, TB
(BCG), polio, and measles – would be less than three
rupees (eight US cents) in the poorest states and even less
in wealthier states [44].
Our study shows that current inadequate levels of immu-
nization coverage in India are only part of the problem.
Gender inequity in access to health programs is responsi-
ble for a considerable number of avoidable deaths. India’s
states could save even more lives by addressing deep-seat-
ed social and cultural issues responsible for gender
discrimination at the household level, where girls are seen
as a burden and boys as a resource [41]. Campaigns to
raise awareness of gender inequities in conjunction with
improvement in vaccine delivery strategies with a focus
on timeliness of coverage may be a means to that end.
Continuing research is needed in order to identify effec-
tive social policies of reducing gender inequities in access
to immunizations and other health practices across India
and other parts of South Asia. 
Conclusions 
In India, inequities in girls’ access to health services have
persisted in recent years. Our research has examined this
disparity through a study of gender inequities in child
immunization coverage. Young girls are especially vulner-
able to these gaps in coverage, but efforts need to be made
to increase overall immunization coverage for both girls
and boys. Over half of children under five are not fully
immunized, and a large proportion of those immunized
are being immunized too late. These two factors can lead
to increased transmissibility of infections, reducing
protective effects of immunization and contributing to
avoidable child deaths. In 2005, over 60 million children
were not appropriately immunized in India.
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Distributions of time to immunization, by antigen, gender and year of birth. 
 
 
Supplement to: Corsi DJ, Bassani DG, Kumar R, et al. Gender inequity and age-appropriate immunization coverage in India from 
1992 to 2006.  
 
This web appendix presents the distributions (box and whisker plots) of the time to vaccination for each antigen by year of birth.  Boys 
and girls are presented separately.  Dashed red lines indicate time of age-appropriate vaccine administration.  Red diamonds indicate 
the mean time to vaccination.  The full data table is also presented.  Children born in 1994, 1995, 2000 and 2006 (for measles only), 
are not covered by the NFHS surveys and no data are presented for these years.     
  
 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25th 11.71 5.29 4.71 4.57 2.86 0.86 2.14 2.00 1.57 0.43 1.71 1.00 1.43 1.00 1.29 0.43
50th 20.86 12.71 11.29 9.86 6.86 5.14 7.00 5.86 5.57 2.57 4.71 4.86 4.71 4.29 4.57 1.86
75th 67.71 32.29 20.29 19.43 12.57 9.14 14.00 12.29 10.29 6.00 9.43 9.00 8.71 9.00 8.57 4.71
99th 176.57 151.71 98.57 69.00 45.86 20.86 90.29 71.86 39.00 20.14 73.14 100.43 59.29 62.00 35.57 12.43
Mean 44.35 25.61 17.26 14.35 9.02 5.88 12.59 10.19 7.35 3.98 9.32 9.66 7.77 8.01 6.46 3.02
SD 47.58 32.36 20.56 14.69 8.83 5.28 18.44 14.21 7.86 4.88 15.00 18.54 ` 11.92 7.26 3.14
Minimum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Maximum 176.57 162.00 131.86 109.86 63.71 20.86 135.00 115.00 83.86 60.43 228.86 166.43 161.43 104.29 67.14 18.71
N 42 435 814 1249 1154 131 546 1081 1341 318 490 844 1008 1349 1780 365
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 0.14 0.00 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25th 10.29 5.29 5.57 4.71 3.43 4.29 2.43 2.14 1.71 0.43 1.14 0.86 0.86 1.00 1.29 0.57
50th 22.29 13.57 11.57 9.43 7.14 6.57 6.71 6.29 5.14 2.00 4.86 4.29 4.57 4.00 4.57 2.29
75th 40.29 27.57 21.57 18.14 12.57 10.71 12.43 11.57 9.43 5.43 10.86 9.57 10.00 8.71 8.71 4.71
99th 170.14 110.14 92.57 65.29 37.71 25.57 113.43 65.43 37.57 18.00 63.29 73.00 101.00 67.86 36.00 14.43
Mean 31.81 21.74 18.20 13.47 9.06 7.50 13.08 9.97 6.92 3.78 9.47 9.53 9.76 7.99 6.53 3.35
SD 36.93 24.24 20.53 13.43 7.88 5.46 20.26 13.14 7.34 5.06 14.29 17.42 17.22 12.83 7.32 3.51
Minimum 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Maximum 170.14 127.71 129.57 108.43 58.00 25.57 140.57 104.00 50.00 64.14 234.14 189.71 153.43 106.00 66.71 22.43
N 51 500 900 1419 1291 150 680 1272 1626 330 511 885 1231 1560 1977 391
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 4.43 0.00 0.43 2.43 1.29 1.57 2.00 0.43 0.57 1.43 2.14 0.71 0.29 0.57 1.14 2.00
25th 11.57 9.86 8.71 8.29 7.14 6.71 7.43 7.00 6.86 6.29 7.00 6.86 7.00 7.00 6.86 6.29
50th 15.29 14.71 12.71 11.71 9.71 8.57 10.14 9.00 8.57 7.14 9.00 8.86 8.86 9.00 8.43 7.00
75th 34.29 32.29 19.00 17.71 13.71 10.00 15.00 13.43 11.86 8.43 13.29 13.14 12.14 13.14 11.71 8.71
99th 183.29 125.14 95.14 65.43 40.86 17.57 112.71 73.00 37.43 18.57 110.71 123.71 65.00 69.00 36.00 16.71
Mean 37.15 27.19 18.75 15.36 11.60 8.90 16.14 13.38 10.49 7.76 15.15 14.84 11.86 12.70 10.18 7.56
SD 45.08 28.75 18.76 11.90 7.22 3.39 18.78 13.86 6.63 3.93 23.44 19.65 12.22 12.17 6.09 2.73
Minimum 4.43 0.00 0.00 0.00 0.14 0.43 0.00 0.00 0.00 0.00 0.14 0.00 0.00 0.00 0.00 0.29
Maximum 183.29 160.29 122.14 95.29 63.71 17.57 126.14 115.00 83.86 60.43 249.00 188.57 147.57 96.86 57.71 19.14
N 49 493 915 1380 1217 114 569 1132 1418 280 510 880 1059 1410 1764 286
* p <0.05 test for difference in mean time to vaccination between girls and boys
POLIO 1 (GIRLS)
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 6.71 0.71 2.14 1.86 1.29 2.14 2.00 1.86 1.29 1.43 1.86 1.14 0.86 1.57 0.57 1.29
25th 12.43 9.71 8.57 7.86 7.14 6.86 7.00 7.14 6.86 6.43 6.86 6.86 6.86 6.86 6.86 6.29
50th 22.29 14.71 12.86 11.29 9.71 8.43 9.14 9.14 8.86 7.29 9.14 8.43 8.71 8.71 8.43 7.14
75th 55.86 25.57 21.00 17.14 13.43 10.57 14.43 13.43 12.29 9.57 13.57 12.29 13.57 12.71 11.29 8.57
99th 188.14 133.57 84.71 63.86 37.29 27.43 112.43 67.29 38.57 18.29 165.71 94.71 120.29 76.14 34.43 15.29
Mean 39.59 23.29 19.22 14.87 11.28 9.37 15.76 13.09 10.54 7.94 15.83 14.87 14.57 12.38 10.00 7.59
SD 44.14 24.67 18.44 11.69 6.52 4.23 19.36 12.41 6.51 3.25 23.74 20.94 18.62 12.32 5.90 2.77
Minimum 4.14 0.43 0.14 0.00 0.14 1.71 0.00 0.00 0.00 0.00 0.57 0.00 0.00 0.00 0.00 0.14
Maximum 188.14 188.43 130.29 98.00 51.29 27.43 141.86 99.14 64.57 38.00 234.29 221.86 153.43 106.00 66.71 18.29
N 67 579 1018 1588 1401 153 704 1325 1677 262 527 928 1280 1615 2013 301
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 8.71 5.00 5.57 7.43 6.71 4.71 7.29 6.29 6.29 5.86 6.29 6.00 6.71 6.71 6.43 7.29
25th 16.86 15.00 14.00 13.71 12.29 12.00 12.57 12.00 11.86 10.57 12.14 12.14 12.43 12.00 12.00 11.00
50th 20.43 19.29 18.14 17.57 15.14 13.57 15.86 14.71 14.00 11.86 14.29 15.00 14.86 14.57 14.00 11.43
75th 33.43 39.00 25.57 24.14 19.57 17.29 22.43 19.86 17.71 13.71 20.00 20.14 19.29 20.29 18.00 13.29
99th 187.57 138.43 98.57 70.29 49.71 25.43 113.14 82.00 41.00 23.71 101.71 137.57 74.57 74.14 42.43 21.43
Mean 41.28 32.09 24.40 20.96 17.07 14.19 22.29 18.82 15.65 12.61 21.27 22.00 18.68 18.98 15.75 12.24
SD 44.35 28.96 18.54 12.03 7.64 4.00 19.23 12.94 6.43 5.50 21.29 21.68 13.27 13.00 6.23 2.76
Minimum 8.71 3.71 3.00 2.86 4.14 4.71 4.00 3.14 0.00 5.00 5.29 2.43 4.29 3.86 3.86 6.43
Maximum 187.57 173.57 113.14 99.43 61.71 25.43 134.86 96.71 79.43 69.14 191.00 173.43 152.14 101.71 60.14 24.86
N 49 478 889 1335 1008 65 549 1105 1235 168 498 869 1034 1370 1592 155
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 11.00 7.00 6.86 6.86 6.57 8.29 7.00 6.43 6.00 7.29 6.71 6.43 6.86 6.71 6.29 7.57
25th 17.71 15.71 13.71 13.29 12.14 11.14 12.29 12.29 11.86 10.71 11.86 11.86 12.14 11.71 11.71 11.14
50th 26.29 20.29 18.29 17.00 15.00 13.14 15.14 15.00 14.29 11.86 14.71 14.57 15.00 14.14 13.86 12.14
75th 58.00 31.29 26.14 22.57 19.14 15.14 21.14 20.29 17.86 14.00 20.14 20.57 21.57 19.86 17.29 14.00
99th 177.71 139.43 92.14 67.86 40.71 23.43 109.29 71.29 39.14 24.43 207.29 91.43 128.57 81.29 40.71 21.43
Mean 38.93 28.39 24.24 20.25 16.49 13.53 20.94 19.13 15.78 12.73 22.81 20.47 21.48 18.64 15.60 12.86
SD 32.64 23.63 18.01 11.32 6.58 3.37 18.30 12.65 6.42 4.05 29.93 16.98 20.21 13.16 6.26 2.75
Minimum 11.00 3.43 2.14 1.00 3.71 6.71 4.71 3.29 1.14 6.43 2.43 0.71 1.57 4.43 1.71 6.57
Maximum 177.71 202.71 134.71 109.00 65.00 25.86 146.14 96.29 66.71 48.00 238.29 217.71 158.43 95.86 56.14 26.57
N 62.00 563.00 992.00 1503.00 1140.00 80.00 678.00 1291.00 1474.00 161.00 515.00 917.00 1260.00 1567.00 1836.00 174.00
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 13.14 10.29 11.14 12.29 10.86 8.86 13.00 10.43 11.00 10.86 11.00 11.00 11.00 11.43 11.00 11.00
25th 21.57 19.43 19.00 18.71 17.57 15.29 17.71 17.00 16.86 13.71 17.29 17.29 17.57 17.29 16.86 15.29
50th 26.14 25.86 24.29 22.86 20.71 18.14 22.00 20.86 19.57 15.71 20.00 20.71 21.00 21.00 19.14 16.29
75th 35.71 42.57 33.43 30.14 24.43 21.43 29.57 27.00 23.71 17.57 27.00 28.57 27.29 28.43 24.00 18.00
99th 191.29 133.86 99.43 74.57 49.71 30.43 118.71 83.57 43.29 35.29 139.00 144.43 87.57 90.14 49.86 23.29
Mean 40.95 36.47 30.74 26.75 22.26 18.71 28.93 25.03 21.20 16.55 28.33 28.54 25.62 25.78 21.34 16.57
SD 37.71 26.97 19.35 13.10 7.36 4.25 19.79 13.59 6.82 6.05 23.40 23.05 14.56 14.48 7.12 2.70
Minimum 13.14 9.43 8.86 6.29 8.29 8.86 9.57 8.43 5.00 10.86 7.14 5.00 8.86 5.57 7.86 10.86
Maximum 191.29 167.57 117.43 105.57 60.57 30.43 127.86 125.86 84.43 73.57 161.14 178.71 142.29 108.14 62.14 25.14
N 45 447 822 1218 759 28 519 1038 1006 80 481 833 977 1313 1327 79
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 16.00 9.71 10.86 12.14 11.14 13.00 11.43 11.57 9.71 12.71 12.43 11.29 12.00 10.86 11.00 11.71
25th 22.71 20.57 18.86 18.29 17.43 15.57 17.57 17.43 16.71 15.14 17.14 17.29 17.29 17.00 16.57 15.86
50th 32.29 25.71 24.00 22.57 20.43 17.43 20.57 21.14 19.57 17.86 20.29 20.86 21.29 20.14 19.00 16.86
75th 66.14 37.71 33.57 28.86 24.57 18.43 28.00 27.86 23.43 20.14 27.14 30.86 30.29 26.57 23.86 17.71
99th 189.71 114.14 96.57 72.86 42.29 27.14 97.14 80.43 47.29 41.00 226.00 119.29 117.00 82.43 46.00 22.00
Mean 47.85 33.40 30.18 25.49 21.70 17.73 26.74 25.62 21.09 18.85 31.11 28.55 27.58 25.02 21.20 16.84
SD 35.55 21.88 18.34 11.24 6.42 3.35 17.23 13.88 6.89 6.44 33.99 20.43 18.41 14.10 6.98 1.89
Minimum 16.00 4.29 7.14 0.29 0.71 12.14 10.29 9.29 5.86 12.43 1.29 5.57 1.71 6.86 6.71 11.14
Maximum 189.71 172.71 139.71 101.57 55.29 27.14 137.29 103.00 79.43 67.71 235.14 222.00 157.29 101.14 57.14 25.86
N 61 534 932 1377 873 42 639 1220 1222 84 502 891 1200 1487 1550 80
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 4.43 0.00 0.43 2.43 1.29 1.57 3.57 1.43 0.71 1.43 2.57 0.71 1.57 1.86 2.00 2.14
25th 12.57 9.71 8.86 8.43 7.29 6.71 7.57 7.00 6.86 6.29 7.14 6.86 7.00 7.00 6.86 6.14
50th 15.29 14.71 13.00 12.00 9.71 8.57 10.29 9.14 8.57 7.14 9.14 8.86 9.00 9.00 8.43 6.86
75th 62.29 32.29 19.86 18.00 13.86 10.00 15.43 13.43 11.71 8.43 13.29 13.29 12.29 13.14 11.86 8.29
99th 183.29 125.00 95.14 65.43 40.71 17.57 113.14 71.86 37.43 18.57 110.71 123.71 65.00 74.29 36.00 16.86
Mean 41.02 27.34 19.15 15.53 11.70 8.89 17.17 13.25 10.47 7.78 15.22 15.56 12.09 13.08 10.32 7.48
SD 48.63 29.59 19.04 11.93 7.20 3.39 19.98 13.42 6.58 3.88 23.33 20.86 12.37 12.84 6.11 2.75
Minimum 4.43 0.00 0.00 0.00 0.14 0.43 0.00 0.00 0.00 0.14 0.71 0.00 0.00 0.00 0.00 0.29
Maximum 183.29 160.29 125.57 95.29 63.71 17.57 126.14 115.00 83.86 60.43 249.00 188.57 138.43 101.14 57.71 18.71
N 50 500 919 1388 1226 115 578 1142 1440 281 513 888 1064 1429 1796 282
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 6.14 2.57 2.86 2.14 1.86 2.14 2.00 2.86 1.43 1.43 2.43 2.29 0.86 1.86 1.43 1.43
25th 12.43 10.14 8.71 8.00 7.14 6.86 7.14 7.14 6.86 6.43 7.00 6.86 6.86 6.86 6.86 6.43
50th 19.14 14.86 13.00 11.57 9.86 8.43 9.14 9.14 8.86 7.29 9.14 8.57 8.71 8.57 8.43 7.14
75th 51.57 26.29 21.29 17.29 13.43 10.57 14.29 13.43 12.43 9.57 13.86 12.86 13.86 12.71 11.14 8.57
99th 188.14 133.57 84.71 63.86 37.71 27.43 107.57 66.00 37.29 18.29 165.71 94.71 120.29 76.14 34.43 15.29
Mean 38.98 24.23 19.39 15.09 11.31 9.36 15.30 13.09 10.51 7.96 15.84 15.24 14.44 12.68 9.99 7.68
SD 44.49 25.65 18.43 11.60 6.53 4.21 18.38 12.10 6.36 3.29 23.47 21.58 18.41 12.75 5.84 2.68
Minimum 4.14 0.71 0.43 0.00 0.14 1.71 0.00 0.00 0.00 0.00 0.57 0.00 0.00 0.00 0.00 0.57
Maximum 188.14 188.43 130.29 98.00 62.00 27.43 141.86 99.14 64.57 38.00 234.29 221.86 153.43 106.00 66.71 18.29
N 67 582 1020 1592 1407 156 706 1338 1700 266 533 943 1292 1632 2040 297
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 8.71 5.00 5.57 7.43 6.71 4.71 7.29 6.43 6.29 5.86 6.29 6.00 6.71 6.86 7.14 7.71
25th 17.57 15.00 14.14 13.86 12.29 12.00 12.71 12.00 11.71 10.57 12.29 12.14 12.57 12.00 12.00 11.00
50th 22.14 19.86 18.29 17.57 15.14 13.57 16.00 14.86 14.00 11.71 14.43 15.00 14.86 14.57 13.86 11.43
75th 65.29 39.86 26.00 24.29 19.57 17.29 22.14 20.00 17.71 13.71 20.14 20.29 19.29 20.29 17.86 13.14
99th 187.57 138.43 98.57 70.29 50.00 25.43 118.71 79.29 41.00 23.71 114.86 137.57 70.00 75.86 39.86 21.43
Mean 45.69 32.77 24.94 20.95 17.19 14.31 22.11 18.89 15.63 12.65 21.75 22.39 18.46 19.12 15.75 12.20
SD 48.61 30.21 19.07 11.95 7.71 4.03 18.61 12.81 6.34 5.47 22.50 22.16 12.41 13.13 6.15 2.64
Minimum 8.71 3.71 3.00 2.86 4.14 4.71 4.00 3.14 0.00 5.00 5.14 2.43 1.29 4.14 3.86 6.43
Maximum 187.57 175.71 138.29 99.43 61.71 25.43 134.86 96.71 79.43 69.14 191.00 173.43 152.14 104.43 60.14 24.86
N 49 481 889 1334 1012 67 554 1110 1251 166 503 874 1033 1386 1608 156
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 11.00 7.00 6.71 7.71 6.57 8.29 7.00 6.86 6.00 7.43 7.00 7.14 6.71 6.29 6.29 7.57
25th 18.57 15.86 13.71 13.29 12.29 11.14 12.29 12.29 11.86 10.71 11.86 12.00 12.14 11.71 11.71 11.14
50th 25.00 20.71 18.29 17.43 15.00 13.14 15.14 15.14 14.29 11.86 14.71 14.71 14.86 14.29 13.86 12.14
75th 55.86 31.43 26.29 23.00 19.14 15.14 21.14 20.43 18.00 14.00 20.14 20.57 21.43 19.71 17.29 14.00
99th 177.71 120.00 92.14 67.86 40.71 23.43 104.14 71.14 37.29 24.14 207.29 94.86 128.57 81.14 38.14 21.43
Mean 40.54 28.34 24.30 20.45 16.55 13.51 20.94 19.08 15.77 12.66 22.83 21.11 21.38 18.69 15.52 12.89
SD 35.92 21.98 17.87 11.39 6.63 3.37 17.82 12.31 6.19 3.98 29.65 18.46 20.09 13.10 6.11 2.81
Minimum 11.00 3.43 2.14 1.00 3.71 6.71 4.71 3.29 1.14 6.43 6.29 0.71 1.14 4.43 1.71 5.57
Maximum 177.71 193.57 134.71 109.00 67.00 25.86 146.14 96.29 66.71 48.00 238.29 217.71 158.43 95.14 56.14 26.57
N 62 561 993 1503 1146 80 682 1299 1490 164 524 922 1278 1586 1852 173
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 13.14 10.29 11.14 11.86 11.00 8.86 13.00 11.00 9.71 10.86 11.00 11.00 11.00 11.57 11.71 11.00
25th 22.14 19.43 19.29 18.71 17.57 16.14 17.71 17.00 16.71 13.71 17.43 17.29 17.57 17.29 16.86 15.43
50th 25.43 25.86 24.57 22.86 20.86 18.14 22.29 21.00 19.43 15.71 20.43 21.00 21.29 21.00 19.14 16.43
75th 35.71 43.14 33.86 30.43 24.57 21.43 29.43 27.14 23.57 17.71 27.43 29.86 27.71 28.57 24.00 18.00
99th 191.29 131.29 99.43 74.57 50.86 30.43 102.00 83.57 43.29 35.29 149.14 144.43 87.57 90.14 49.86 25.14
Mean 38.60 35.99 31.12 26.78 22.27 18.79 28.08 25.19 21.08 16.52 29.18 29.36 26.09 25.93 21.42 16.85
SD 32.62 26.32 19.50 13.13 7.35 4.19 17.60 13.66 6.75 6.06 24.83 23.84 14.69 14.67 7.06 2.46
Minimum 13.14 9.43 8.86 6.29 8.29 8.86 9.57 8.43 5.00 8.71 7.14 5.00 6.29 5.57 7.86 10.86
Maximum 191.29 184.57 117.43 109.86 60.57 30.43 127.86 125.86 84.43 73.57 178.00 178.71 142.29 108.14 62.43 25.14
N 41 449 821 1215 768 28 519 1041 1019 80 494 841 984 1330 1340 77
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 8.14 9.86 10.86 12.14 11.14 12.43 11.43 12.00 9.71 12.43 12.71 11.43 10.86 10.86 11.43 11.14
25th 22.57 20.71 18.86 18.43 17.43 15.43 17.57 17.43 16.71 15.14 17.14 17.29 17.29 17.00 16.57 15.86
50th 30.00 26.29 24.00 22.71 20.43 17.00 20.71 21.29 19.71 17.86 20.71 20.86 21.29 20.14 19.14 17.00
75th 60.29 39.43 33.29 28.71 24.57 18.43 28.00 27.86 23.43 20.14 27.43 30.71 29.86 26.57 23.86 17.71
99th 189.71 129.43 96.57 72.86 42.29 27.14 92.86 80.43 47.86 41.00 226.00 122.71 117.00 80.43 46.00 22.00
Mean 46.60 34.56 29.99 25.61 21.76 17.66 26.44 25.50 21.16 18.77 31.19 28.58 27.41 24.97 21.30 16.85
SD 38.59 23.17 17.98 11.36 6.51 3.40 15.87 13.52 6.99 6.48 33.41 20.74 18.28 13.84 6.98 1.87
Minimum 8.14 4.29 7.14 0.29 0.71 8.00 10.29 9.29 5.86 7.00 1.29 5.57 1.71 6.86 6.71 9.71
Maximum 189.71 172.71 139.71 101.57 55.29 27.14 114.57 103.00 79.43 67.71 235.14 222.00 162.29 101.14 57.14 25.86
N 61 537 932 1372 881 43 638 1225 1226 86 507 893 1214 1497 1566 80
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 35.14 15.57 18.43 10.71 9.71 20.14 19.57 22.00 7.14 19.29 19.29 14.14 24.86 24.43
25th 40.14 40.00 38.71 38.00 36.57 39.43 39.29 39.14 7.14 39.71 39.57 39.86 39.71 38.57
50th 42.71 46.00 43.00 41.43 39.86 42.29 42.43 41.14 39.86 42.29 42.71 42.57 42.71 40.57
75th 65.57 65.57 52.43 46.86 43.29 49.57 47.29 44.29 41.00 47.86 52.14 48.57 47.86 43.00
99th 191.29 124.86 105.00 88.57 58.00 108.57 91.71 59.43 41.00 202.29 173.00 123.00 93.29 54.71
Mean 60.00 54.80 48.61 43.28 39.92 47.97 44.99 41.67 26.80 48.36 50.74 47.76 46.47 40.70
SD 34.21 24.59 17.59 11.50 7.70 16.93 11.72 6.44 20.09 25.35 23.90 17.71 12.54 5.09
Minimum 34.00 0.00 1.57 1.29 2.00 9.00 0.86 1.29 7.14 8.86 11.57 2.71 9.29 10.00
Maximum 191.29 173.86 167.86 96.86 67.86 129.43 101.00 87.57 41.00 250.71 197.00 153.71 112.43 65.29
N 34.00 370.00 658.00 873.00 277.00 444.00 893.00 441.00 3.00 459.00 789.00 913.00 1225.00 638.00
* p <0.05 test for difference in mean time to vaccination between girls and boys
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*1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
1st 21.14 13.86 12.71 15.43 12.29 17.43 17.57 1.57 5.57 22.86 29.14 21.14 18.71 15.29
25th 41.57 39.14 39.14 38.00 36.43 39.86 39.57 38.86 39.43 39.57 39.57 39.86 39.29 39.00
50th 55.71 43.71 43.29 41.57 40.00 42.71 42.43 40.71 40.57 42.86 42.86 42.71 41.71 40.71
75th 87.29 59.00 54.00 47.00 42.57 49.14 47.43 43.71 45.29 48.86 51.86 48.86 46.57 43.14
99th 180.71 123.43 120.43 84.86 56.00 114.86 94.29 56.71 67.71 183.00 155.14 132.43 90.43 55.14
Mean 73.80 52.58 50.09 44.08 39.16 47.39 44.84 40.79 39.92 50.45 50.88 49.15 44.43 40.67
SD 43.25 23.91 19.65 11.56 7.73 16.54 11.51 7.69 17.03 26.95 22.15 20.80 11.50 6.03
Minimum 21.14 3.43 0.00 1.71 3.86 10.71 0.14 0.00 5.57 5.14 5.57 3.29 2.43 4.57
Maximum 180.71 193.57 144.71 117.14 63.14 137.71 106.57 113.29 67.71 234.57 220.43 163.71 99.57 65.29
N 42.00 441.00 759.00 1023.00 317.00 572.00 1027.00 533.00 9.00 465.00 821.00 1129.00 1396.00 763.00
* p <0.05 test for difference in mean time to vaccination between girls and boys
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